


St Pharm
Pharmaceutical Manufacturing • 520, Yeongdong-daero, Korea, Republic of • 101-200 Employees
Company overview
| Headquarters | 520, Yeongdong-daero, Gangnam-gu, 7F, Seoul, 06170, KR |
| Phone number | +8225276300 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | New Drug Apis & Intermediates (Anti Hcv/Hiv/Aids), Lnp), Mrna Cdmo (5'-Cap |
| Founded | 1983 |
| Employees | 101-200 |
| Socials |
Key Contacts at St Pharm
Sung-Jin Choi
Director, Head Of Business Division Ii
Geun Jho Lim
Ceo
임 근조
Ceo
St Pharm Email Formats
St Pharm uses 1 email format. The most common is {first name} (e.g., john@stpharm.co.kr), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@stpharm.co.kr | 100% |
About St Pharm
“ST Pharm provides reliable and timely custom manufacturing services for API following stringent quality system and close communication with the clients.” Founded in 1983, ST Pharm (formerly known as Samchully Pharmaceutical) has been offering excellent custom manufacturing services of APIs and their intermediates to meet clients’ high expectation for their use in pharmaceutical development in compliant to cGMP requirements. Our reliability in service, which is well-proven through decades of business relationship with many big pharmas and biotech clients, is the essence of our strength along with our expertise in process development and scale-up optimization. Historically, ST Pharm has been focusing our expertise on nucleoside based active pharmaceuticals in various antiviral drug applications; we became the world largest supplier of Thymidine in the late 1990s and Zidovudine in the mid 2000s and protected nucleosides in the early 2000s. ST Pharm has continuously been expanding its service offering, including synthesis of therapeutic oligonucleotides. In June 2010, ST Pharm became a subsidiary of Dong-A Pharmaceutical, the top pharmaceutical company in Korea. ST Pharm is committed to expanding its business scope into generic APIs and their intermediates with full support and collaboration with parent company Dong-A Pharmaceutical.
St Pharm revenue & valuation
| Annual revenue | $197,600,000 |
| Revenue per employee | $1,442,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $632,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
St Pharm has 39 employees across 8 departments.
Departments
Number of employees
St Pharm Tech Stack
Discover the technologies and tools that power St Pharm's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Programming languages
JavaScript libraries
CDN
Video players
JavaScript libraries
JavaScript libraries
Security
UI frameworks
Widgets
JavaScript libraries
JavaScript graphics
Frequently asked questions
4.8
40,000 users



